{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:10:48Z","timestamp":1789099848968,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["52273308"],"award-info":[{"award-number":["52273308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["52273308"],"award-info":[{"award-number":["52273308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-025-02419-2","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:36:25Z","timestamp":1758879385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Health-related quality of life and financial toxicity in Chinese patients with multiple myeloma: a two-year real-world multicentre study"],"prefix":"10.1186","volume":"23","author":[{"given":"Weijia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqianzi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiquan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"9","key":"2419_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaoncol.2018.2128","volume":"4","author":"AJ Cowan","year":"2018","unstructured":"Cowan AJ, Allen C, Barac A, et al. Global burden of multiple myeloma: A systematic analysis for the global burden of disease study 2016. JAMA Oncol. 2018;4(9):1221\u20137.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2419_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ccell.2015.10.014","volume":"28","author":"E Braggio","year":"2015","unstructured":"Braggio E, Kort\u00fcm KM, Stewart AK. SnapShot: multiple myeloma. Cancer Cell. 2015;28(5):678\u2013e6781.","journal-title":"Cancer Cell"},{"issue":"5","key":"2419_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1200\/JCO.2009.25.4177","volume":"28","author":"I Turesson","year":"2010","unstructured":"Turesson I, Velez R, Kristinsson SY, Landgren O. Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol. 2010;28(5):830\u20134.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2419_CR4","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/leu.2013.313","volume":"28","author":"SK Kumar","year":"2014","unstructured":"Kumar SK, Dispenzieri A, Lacy MQ, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014;28(5):1122\u20138.","journal-title":"Leukemia"},{"issue":"4","key":"2419_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/ajco.13901","volume":"19","author":"H Jiang","year":"2023","unstructured":"Jiang H, Lyu J, Mou W, Jiang Q, Du J. Association between financial toxicity and health-related quality of life in cancer survivors: A systematic review. Asia Pac J Clin Oncol. 2023;19(4):439\u201357. https:\/\/doi.org\/10.1111\/ajco.13901.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"2419_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00520-020-05468-z","volume":"29","author":"ES Ver Hoeve","year":"2021","unstructured":"Ver Hoeve ES, Ali-Akbarian L, Price SN, Lothfi NM, Hamann HA. Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors. Support Care Cancer. 2021;29(1):349\u201358. https:\/\/doi.org\/10.1007\/s00520-020-05468-z.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2419_CR7","doi-asserted-by":"publisher","first-page":"e235897","DOI":"10.1001\/jamanetworkopen.2023.5897","volume":"6","author":"LV Ghazal","year":"2023","unstructured":"Ghazal LV, Abrahamse P, Ward KC, Morris AM, Hawley ST, Veenstra CM. Financial toxicity and its association with Health-Related quality of life among partners of colorectal cancer survivors. JAMA Netw Open. 2023;6(4):e235897. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.5897. Published 2023 Apr 3.","journal-title":"JAMA Netw Open"},{"key":"2419_CR8","doi-asserted-by":"publisher","first-page":"e2400043","DOI":"10.1200\/GO.24.00043","volume":"10","author":"A Chan","year":"2024","unstructured":"Chan A, Ke Y, Tanay M, et al. Financial toxicity in cancer supportive care: an international survey. JCO Glob Oncol. 2024;10:e2400043. https:\/\/doi.org\/10.1200\/GO.24.00043.","journal-title":"JCO Glob Oncol"},{"key":"2419_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K, Blinder V, Ara\u00fajo FS, Hlubocky FJ, Nicholas LH, O\u2019Connor JM, Brockstein B, Ratain MJ, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the comprehensive score for financial toxicity (COST). Cancer. 2017;123:476\u201384.","journal-title":"Cancer"},{"issue":"10","key":"2419_CR10","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","volume":"2","author":"SF Huntington","year":"2015","unstructured":"Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2(10):e408\u201316.","journal-title":"Lancet Haematol"},{"issue":"7","key":"2419_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.clml.2024.02.013","volume":"24","author":"R Banerjee","year":"2024","unstructured":"Banerjee R, Cowan AJ, Ortega M, Missimer C, Carpenter PA, Oshima MU, Salit RB, Vo PT, Lee CJ, Mehta RS, Kuderer NM, Shankaran V, Lee SJ, Su CT. Financial toxicity, time toxicity, and quality of life in multiple myeloma. Clin Lymphoma Myeloma Leuk. 2024;24(7):446\u2013e4543.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2419_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-025-01711-4","volume":"18","author":"I Ntanasis-Stathopoulos","year":"2025","unstructured":"Ntanasis-Stathopoulos I, Malandrakis P, Gavriatopoulou M. Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meeting. J Hematol Oncol. 2025;18(1):54. https:\/\/doi.org\/10.1186\/s13045-025-01711-4. Published 2025 May 13.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2419_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ijrobp.2022.11.040","volume":"116","author":"MA Dar","year":"2023","unstructured":"Dar MA, Chauhan R, Trivedi V, Kumar R, Dhingra S. Assessing the prevalence of financial toxicity, its predictors and association with Health- related quality of life among radiation oncology patients in india: A Cross-Sectional patient reported outcome study. Int J Radiat Oncol Biol Phys. 2023;116(1):157\u201365. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.11.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2419_CR14","doi-asserted-by":"publisher","first-page":"e246872","DOI":"10.1001\/jamanetworkopen.2024.6872","volume":"7","author":"ML Hsu","year":"2024","unstructured":"Hsu ML, Boulanger MC, Olson S, et al. Unmet needs, quality of life, and financial toxicity among survivors of lung cancer. JAMA Netw Open. 2024;7(4):e246872. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.6872. Published 2024 Apr 1.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2419_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2022.07.017","volume":"26","author":"S Pangestu","year":"2023","unstructured":"Pangestu S, Rencz F. Comprehensive score for financial toxicity and Health-Related quality of life in patients with cancer and survivors: A systematic review and Meta-Analysis. Value Health. 2023;26(2):300\u201316. https:\/\/doi.org\/10.1016\/j.jval.2022.07.017.","journal-title":"Value Health"},{"issue":"2","key":"2419_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.31557\/APJCP.2020.21.2.289","volume":"21","author":"LA Nogueira","year":"2020","unstructured":"Nogueira LA, Lenhani BE, Tomim DH, Kalinke LP. Financial toxicity. Asian Pac J Cancer Prev. 2020;21(2):289\u201393. https:\/\/doi.org\/10.31557\/APJCP.2020.21.2.289. Published 2020 Feb 1.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2419_CR17","first-page":"5693","volume":"28","author":"F Mols","year":"2020","unstructured":"Mols F, Tomalin B, Pearce A, et al. Financial toxicity and employment status in cancer survivors. A systematic literature review. Support Care Cancer. 2020;28:5693\u2013708.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2419_CR18","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1002\/cam4.5244","volume":"12","author":"M Liu","year":"2023","unstructured":"Liu M, Huang D, Liu Y. Financial toxicity of patients with lung cancer in china: results from a National survey study. Cancer Med. 2023;12(4):4751\u201360. https:\/\/doi.org\/10.1002\/cam4.5244.","journal-title":"Cancer Med"},{"key":"2419_CR19","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S1474-4422(15)00200-8","volume":"14","author":"IJ Marshall","year":"2015","unstructured":"Marshall IJ, Wang Y, Crichton S, McKevitt C, Rudd AG, Wolfe CD. The effects of socioeconomic status on stroke risk and outcomes. Lancet Neurol. 2015;14:1206\u201318.","journal-title":"Lancet Neurol"},{"issue":"12","key":"2419_CR20","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"issue":"10","key":"2419_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res."},{"key":"2419_CR22","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide, Version 3.0. 2019. https:\/\/euroqol.org\/publications\/user-guides . Accessed 16 Aug 2022."},{"issue":"4","key":"2419_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","volume":"20","author":"N Luo","year":"2017","unstructured":"Luo N, Liu G, Li M, et al. Estimating an EQ-5D-5L value set for China[J]. Value Health. 2017;20(4):662\u201369.","journal-title":"Value Health"},{"issue":"21","key":"2419_CR24","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1182\/blood.V118.21.4184.4184","volume":"118","author":"M Weiss","year":"2011","unstructured":"Weiss M, Jacobus S, Wagner LI, Cella D, Katz MS, Rajkumar V, et al. Development of the functional assessment of cancer therapy-multiple myeloma (FACT-MM) scale and validation in the Eastern cooperative oncology group trial E1A05. Blood. 2011;118(21):4184.","journal-title":"Blood"},{"issue":"1","key":"2419_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-1-79","volume":"1","author":"K Webster","year":"2003","unstructured":"Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1(1):79.","journal-title":"Health Qual Life Outcomes"},{"key":"2419_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1136\/bmj.n604","volume":"373","author":"YB Zhang","year":"2021","unstructured":"Zhang YB, Chen C, Pan XF, et al. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373:604. https:\/\/doi.org\/10.1136\/bmj.n604. Published 2021 Apr 14.","journal-title":"BMJ."},{"key":"2419_CR27","doi-asserted-by":"publisher","first-page":"102831","DOI":"10.1016\/j.eclinm.2024.102831","volume":"76","author":"K Wang","year":"2024","unstructured":"Wang K, Fang Y, Zheng R, et al. Associations of socioeconomic status and healthy lifestyle with incident dementia and cognitive decline: two prospective cohort studies. EClinicalMedicine. 2024;76:102831. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102831. Published 2024 Sep 16.","journal-title":"EClinicalMedicine"},{"issue":"9","key":"2419_CR28","doi-asserted-by":"publisher","first-page":"100618","DOI":"10.1016\/j.lanhl.2024.07.001","volume":"5","author":"Y Wang","year":"2024","unstructured":"Wang Y, Liu M, Yang F, Chen H, Wang Y, Liu J. The associations of socioeconomic status, social activities, and loneliness with depressive symptoms in adults aged 50 years and older across 24 countries: findings from five prospective cohort studies. Lancet Healthy Longev. 2024;5(9):100618. https:\/\/doi.org\/10.1016\/j.lanhl.2024.07.001.","journal-title":"Lancet Healthy Longev"},{"issue":"12","key":"2419_CR29","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2666-7568(23)00211-8","volume":"4","author":"R Li","year":"2023","unstructured":"Li R, Li R, Xie J, et al. Associations of socioeconomic status and healthy lifestyle with incident early-onset and late-onset dementia: a prospective cohort study. Lancet Healthy Longev. 2023;4(12):e693\u2013702. https:\/\/doi.org\/10.1016\/S2666-7568(23)00211-8.","journal-title":"Lancet Healthy Longev"},{"issue":"5","key":"2419_CR30","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s11136-021-03037-3","volume":"31","author":"I R\u00f6sel","year":"2022","unstructured":"R\u00f6sel I, Serna-Higuita LM, Al Sayah F, et al. What difference does multiple imputation make in longitudinal modeling of EQ-5D-5L data? Empirical analyses of simulated and observed missing data patterns. Qual Life Res. 2022;31(5):1521\u201332. https:\/\/doi.org\/10.1007\/s11136-021-03037-3.","journal-title":"Qual Life Res"},{"issue":"8","key":"2419_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/17474086.2019.1634541","volume":"12","author":"M Martino","year":"2019","unstructured":"Martino M, Rossi M, Ferreri A, et al. Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials. Expert Rev Hematol. 2019;12(8):665\u201384. https:\/\/doi.org\/10.1080\/17474086.2019.1634541.","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"2419_CR32","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.bbmt.2018.03.027","volume":"24","author":"R Chakraborty","year":"2018","unstructured":"Chakraborty R, Hamilton BK, Hashmi SK, Kumar SK, Majhail NS. Health-Related quality of life after autologous stem cell transplantation for multiple myeloma. Biol Blood Marrow Transpl. 2018;24(8):1546\u201353. https:\/\/doi.org\/10.1016\/j.bbmt.2018.03.027.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"2419_CR33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/ajh.27326","volume":"99","author":"R Silbermann","year":"2024","unstructured":"Silbermann R, Laubach J, Kaufman JL, et al. Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN. Am J Hematol. 2024;99(7):1257\u201368. https:\/\/doi.org\/10.1002\/ajh.27326.","journal-title":"Am J Hematol"},{"issue":"1","key":"2419_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/bjh.17435","volume":"194","author":"T Plesner","year":"2021","unstructured":"Plesner T, Dimopoulos MA, Oriol A, et al. Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial. Br J Haematol. 2021;194(1):132\u20139. https:\/\/doi.org\/10.1111\/bjh.17435.","journal-title":"Br J Haematol"},{"issue":"12","key":"2419_CR35","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s00277-018-3446-y","volume":"97","author":"R Abonour","year":"2018","unstructured":"Abonour R, Wagner L, Durie BGM, Jagannath S, Narang M, Terebelo HR, et al. Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the connect\u00ae MM registry. Ann Hematol. 2018;97(12):2425\u201336.","journal-title":"Ann Hematol"},{"key":"2419_CR36","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/hec.3871","volume":"28","author":"AJ Hatswell","year":"2019","unstructured":"Hatswell AJ, Burns D, Baio G, et al. Frequentist and bayesian meta-regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data. Health Econ. 2019;28:653\u201365.","journal-title":"Health Econ"},{"issue":"21","key":"2419_CR37","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1002\/cam4.3391","volume":"9","author":"X Li","year":"2020","unstructured":"Li X, Liu J, Chen M, et al. Health-related quality of life of patients with multiple myeloma: A real-world study in China. Cancer Med. 2020;9(21):7896\u2013913. https:\/\/doi.org\/10.1002\/cam4.3391.","journal-title":"Cancer Med"},{"issue":"1","key":"2419_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler DL, Cosman F, Stad RK, Ferrari S. Denosumab in the treatment of osteoporosis: 10 years later: A narrative review. Adv Ther. 2022;39(1):58\u201374.","journal-title":"Adv Ther"},{"issue":"10","key":"2419_CR39","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/cncr.34134","volume":"128","author":"EK O\u2019Donnell","year":"2022","unstructured":"O\u2019Donnell EK, Shapiro YN, Yee AJ, et al. Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma. Cancer. 2022;128(10):1996\u20132004. https:\/\/doi.org\/10.1002\/cncr.34134.","journal-title":"Cancer"},{"issue":"1","key":"2419_CR40","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1002\/onco.13544","volume":"26","author":"MC Politi","year":"2021","unstructured":"Politi MC, Yen RW, Elwyn G, et al. Women who are young, Non-White, and with lower socioeconomic status report higher financial toxicity up to 1 year after breast cancer surgery: A Mixed-Effects regression analysis. Oncologist. 2021;26(1):e142\u201352. https:\/\/doi.org\/10.1002\/onco.13544.","journal-title":"Oncologist"},{"issue":"1","key":"2419_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-023-02194-y","volume":"21","author":"YA Sun","year":"2023","unstructured":"Sun YA, Kalpakavadi S, Prior S, et al. Socioeconomic status and health-related quality of life after stroke: a systematic review and meta-analysis. Health Qual Life Outcomes. 2023;21(1):115. https:\/\/doi.org\/10.1186\/s12955-023-02194-y. Published 2023 Oct 25.","journal-title":"Health Qual Life Outcomes."},{"issue":"2","key":"2419_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/bjh.14213","volume":"175","author":"K Yong","year":"2016","unstructured":"Yong K, Delforge M, Driessen C, et al. Multiple myeloma: patient outcomes in real-world practice. Br J Haematol. 2016;175(2):252\u201364. https:\/\/doi.org\/10.1111\/bjh.14213.","journal-title":"Br J Haematol"},{"issue":"3","key":"2419_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s40487-024-00291-6","volume":"12","author":"TE Delea","year":"2024","unstructured":"Delea TE, Ma Q, Kroog GS, et al. From Triple- to Penta-Exposed multiple myeloma: A Real-World study in a medicare population. Oncol Ther. 2024;12(3):565\u201383. https:\/\/doi.org\/10.1007\/s40487-024-00291-6.","journal-title":"Oncol Ther"},{"issue":"12","key":"2419_CR44","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s40273-019-00828-y","volume":"37","author":"S Fu","year":"2019","unstructured":"Fu S, Wu CF, Wang M, Lairson DR. Cost effectiveness of transplant, conventional chemotherapy, and novel agents in multiple myeloma: A systematic review. PharmacoEconomics. 2019;37(12):1421\u201349.","journal-title":"PharmacoEconomics"},{"issue":"5","key":"2419_CR45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s41669-024-00503-9","volume":"8","author":"DB Bayani","year":"2024","unstructured":"Bayani DB, Lin YC, Nagarajan C, et al. Modeling First-Line daratumumab use for newly diagnosed, Transplant-Ineligible, multiple myeloma: A Cost-Effectiveness and risk analysis for healthcare payers. Pharmacoecon Open. 2024;8(5):651\u201364.","journal-title":"Pharmacoecon Open"},{"issue":"3","key":"2419_CR46","doi-asserted-by":"publisher","first-page":"e213497","DOI":"10.1001\/jamanetworkopen.2021.3497","volume":"4","author":"HM Blommestein","year":"2021","unstructured":"Blommestein HM, Franken MG, van Beurden-Tan CHY, et al. Cost-effectiveness of novel treatment sequences for Transplant-Ineligible patients with multiple myeloma. JAMA Netw Open. 2021;4(3):e213497.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2419_CR47","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1182\/bloodadvances.2024014821","volume":"9","author":"OO Odejide","year":"2025","unstructured":"Odejide OO, Cronin AM, Gray TF, et al. Anxiety and depression among patients newly diagnosed with lymphoma and myeloma. Blood Adv. 2025;9(7):1618\u201329. https:\/\/doi.org\/10.1182\/bloodadvances.2024014821.","journal-title":"Blood Adv"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-025-02419-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-025-02419-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:12:20Z","timestamp":1759972340000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-025-02419-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2419"],"URL":"https:\/\/doi.org\/10.1186\/s12955-025-02419-2","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been updated to correct an erroneous affiliation.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Zhejiang University School of Public Health and performed according to the Declaration of Helsinki. Ethics approval number: ZGL202008-1. Written informed consent was obtained for all participants in cross-section study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval nd consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}